サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1520468

グライコミクス市場レポート：製品、用途、エンドユーザー、地域別、2024年～2032年

Glycomics Market Report by Product, Application, End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations ), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 136 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
グライコミクス市場レポート：製品、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のグライコミクスの市場規模は2023年に15億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに41億米ドルに達し、2024年から2032年の間に11.17%の成長率（CAGR）を示すと予測しています。大衆の間で慢性疾患が蔓延していること、糖鎖工学技術への注目が高まっていること、医薬品や生物製剤に携わる受託研究機関（CRO）の数が増加していることなどが、市場を推進している主な要因です。

グライコミクスは、生体システムにおける糖質、特に糖鎖の包括的研究に焦点を当てた科学分野です。その目的は、糖鎖の構造、組成、機能、および他の生体分子との相互作用を理解することです。グライコームを解析することにより、研究者は糖鎖が生物学的プロセスにどのように影響し、健康や疾病にどのように寄与しているかを明らかにすることができます。この学際的な分野は、化学、生化学、分子生物学、情報学の側面を組み合わせて、糖鎖の構造と機能の複雑さを解明します。研究から得られた洞察は、医学、医薬品開発、バイオマーカー探索、個別化治療など、さまざまな領域にわたって意味を持っています。

世界市場の主な原動力は、慢性疾患の有病率の増加です。さらに、グライコエンジニアリングへの注目の高まりが市場を支えています。グライコエンジニアリングは、治療薬、ワクチン、バイオテクノロジーなど、さまざまな用途のために糖鎖を修飾または操作することを含むからです。これとは別に、ヘルスケアとバイオテクノロジーの発展におけるグライコミクスの可能性を認識している政府、研究機関、および民間投資家は、詳細な研究の実施、新技術の開発、およびグライコミクスに基づく製品の商業化の探求のための投資を提供し、市場を後押ししています。さらに、教育やトレーニングの分野でも世界的に人気が高まっています。さらに、医薬品や生物製剤の研究開発と生産に携わる受託研究機関（CRO）の数が増加していることも、市場の成長を後押ししています。その他、製薬業界の拡大、臨床試験の増加、ヘルスケアインフラの進歩なども市場に影響を与えています。

グライコミクス市場動向/促進要因：

研究開発活動の活発化

市場は研究開発（R&D）活動の著しい盛り上がりを見せています。さまざまな生物学的プロセスにおいて糖鎖が果たす重要な役割に対する理解が深まり、これらの分子の研究や操作に対する関心が高まっています。研究者や製薬会社は、創薬、個別化医療、診断における糖鎖の潜在的な応用を探る研究に投資しています。さらに、分析技術やテクノロジーの継続的な進歩により、調査範囲が拡大しています。さらに、学界、産業界、研究機関の共同研究がグライコミクスの研究開発に拍車をかけています。これらの共同研究は多様な専門知識とリソースを結集し、イノベーションを促進し、グライコミクスに基づく製品開発を加速します。さらに、さまざまな利害関係者が協力することで、知識の拡大、新技術の開発、研究成果の実用化に貢献しています。

個別化医療に対する需要の高まり

個別化医療とは、遺伝的体質や特定の特徴に基づいて個々の患者に合わせた治療を行うことを目的としたもので、注目されつつあります。糖鎖はさまざまな疾病に関与しており、診断や予後予測のための潜在的なバイオマーカーとして機能する可能性があるため、個別化医療において極めて重要な役割を果たしています。患者のグライコームを分析し理解する能力は、標的治療やより正確な医療介入の開発を可能にします。さらに、糖鎖マイクロアレイや糖鎖シーケンシングなどの糖鎖プロファイリング技術の進歩により、疾患特異的な糖鎖シグネチャーの同定が容易になりました。これらの発見は、糖鎖ベースの診断、個別化治療、コンパニオン診断の開発に有望であり、グライコミクスの研究および製品の需要をさらに促進しています。

バイオマーカー探索への注目の高まり

グライコミクスはバイオマーカー探索の分野で大きな注目を集めています。糖鎖は、がん、心血管疾患、感染症など様々な疾患のバイオマーカーとして有望な可能性を示しています。バイオマーカーは、疾患の診断、予後、治療効果のモニタリングにおいて重要な役割を果たしています。さらに、バイオマーカー探索への注目の高まりは、信頼性が高く特異的なバイオマーカーの同定が、疾患の発見、患者の層別化、治療法の選択を改善する上で極めて重要であることから、調査需要を後押ししています。さらに、バイオマーカー探索パイプラインへのグライコミクスの統合は、診断学に革命をもたらし、早期介入を可能にする可能性を秘めており、市場全体の成長を促進しています。また、この調査は、さまざまな疾患に関連する特定の糖鎖パターンや変化を同定するまたとない機会を提供します。個人または患者コホートのグリカムを調査することにより、研究者は診断または予後のバイオマーカーとして機能する疾患特異的な糖鎖シグネチャーを明らかにすることができます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のグライコミクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 酵素
    • 市場動向
    • 主要セグメント
      • グリコシダーゼ
      • グリコシルトランスフェラーゼ
      • ノイラミニダーゼ
      • シアリルトランスフェラーゼ
      • その他
    • 市場予測
  • 機器
    • 市場動向
    • 主要セグメント
      • 質量分析計
      • HPLC
      • MALDI-TOF
      • アレイシステム
      • その他
    • 市場予測
  • キット
    • 市場動向
    • 主要セグメント
      • グリカン標識キット
      • グリカン精製キット
      • グリカン放出キット
      • その他
    • 市場予測
  • 試薬
    • 市場動向
    • 主要セグメント
      • 糖タンパク質
      • 単糖類
      • オリゴ糖
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 創薬と開発
    • 市場動向
    • 市場予測
  • 診断
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 学術研究機関
    • 市場動向
    • 市場予測
  • 製薬・バイオテクノロジー企業
    • 市場動向
    • 市場予測
  • 契約研究機関（CRO）
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Danaher Corporation
    • Dextra Laboratories Limited（New Zealand Pharmaceuticals Limited）
    • Merck KGaA
    • New England Biolabs
    • RayBiotech Life Inc.
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Glycomics Market: Major Drivers and Challenges
  • Figure 2: Global: Glycomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Glycomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Glycomics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Glycomics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Glycomics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Glycomics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Glycomics (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Glycomics (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Glycomics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Glycomics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Glycomics (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Glycomics (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Glycomics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Glycomics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Glycomics (Drug Discovery and Development) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Glycomics (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Glycomics (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Glycomics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Glycomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Glycomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Glycomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Glycomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Glycomics (Contract Research Organizations-CROs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Glycomics (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Glycomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Glycomics Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Glycomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Glycomics Industry: SWOT Analysis
  • Figure 78: Global: Glycomics Industry: Value Chain Analysis
  • Figure 79: Global: Glycomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Glycomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Glycomics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Glycomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Glycomics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Glycomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Glycomics Market: Competitive Structure
  • Table 7: Global: Glycomics Market: Key Players
目次
Product Code: SR112024A5689

The global glycomics market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.17% during 2024-2032. The growing prevalence of chronic diseases among the masses, the rising focus on glycoengineering techniques, and the growing number of contract research organizations (CROs) involved in drug and biologics are some of the major factors propelling the market.

Glycomics is a scientific field that focuses on the comprehensive study of carbohydrates, specifically glycans, in biological systems. It aims to understand the structure, composition, and functions of glycans, as well as their interactions with other biomolecules. By analyzing the glycome, researchers can determine how glycans influence biological processes and contribute to health and disease. This interdisciplinary field combines aspects of chemistry, biochemistry, molecular biology, and informatics to unravel the complexities of glycan structures and functions. The insights gained from the research have implications across various domains, including medicine, drug development, biomarker discovery, and personalized therapeutics.

The global market is primarily driven by the growing prevalence of chronic diseases. Moreover, the increasing focus on glycoengineering is supporting the market as glycoengineering involves the modification or manipulation of glycans for various applications, including therapeutics, vaccines, and biotechnology. Apart from this, Governments, research organizations, and private investors are recognizing the potential of glycomics in advancing healthcare and biotechnology and are providing investments to conduct in-depth studies, develop new technologies, and explore the commercialization of glycomics-based products, providing a boost to the market. Furthermore, it is gaining popularity in the field of education and training worldwide. Additionally, the growing number of contract research organizations (CROs) involved in drug and biologics development and production is augmenting the market growth. Other factors, such as expanding pharmaceutical industry, increasing number of clinical trials, and advancements in healthcare infrastructure, are also influencing the market.

Glycomics Market Trends/Drivers:

Increasing Research and Development Activities

The market is experiencing a significant boost in research and development (R&D) activities. The growing understanding of the crucial roles played by glycans in various biological processes has increased interest in studying and manipulating these molecules. Researchers and pharmaceutical companies are investing in research to explore the potential applications of glycans in drug discovery, personalized medicine, and diagnostics. Moreover, the expanding scope of the research is driven by continuous advancements in analytical techniques and technologies. Furthermore, collaborations between academia, industry, and research institutions have fueled the growth of glycomics R&D. These collaborations bring together diverse expertise and resources, fostering innovation and accelerating the development of glycomics-based products. Additionally, the collaborative efforts between various stakeholders contribute to the expansion of knowledge, development of new technologies, and translation of research findings into practical applications.

Rising Demand for Personalized Medicine

Personalized medicine, which aims to tailor medical treatments to individual patients based on their genetic makeup and specific characteristics, is gaining prominence. It plays a pivotal role in personalized medicine as glycans have been implicated in various diseases and can serve as potential biomarkers for diagnostics and prognostics. The ability to analyze and understand the glycome of patients can enable the development of targeted therapies and more precise medical interventions. In addition, the advancements in glycomics profiling technologies, such as glycan microarrays and glycan sequencing, have facilitated the identification of disease-specific glycan signatures. These discoveries hold promise for the development of glycan-based diagnostics, personalized therapeutics, and companion diagnostics, further fueling the demand for glycomics research and products.

Increasing Focus on Biomarker Discovery

Glycomics has gained significant attention in the field of biomarker discovery. Glycans have shown promising potential as biomarkers for various diseases, including cancer, cardiovascular disorders, and infectious diseases. Biomarkers play a crucial role in disease diagnosis, prognosis, and monitoring treatment efficacy. Moreover, the growing focus on biomarker discovery has propelled the demand for research, as the identification of reliable and specific biomarkers is crucial for improving disease detection, patient stratification, and treatment selection. Furthermore, the integration of glycomics into biomarker discovery pipelines has the potential to revolutionize diagnostics and enable early intervention, driving the growth of the overall market. Also, the research offers a unique opportunity to identify specific glycan patterns or alterations associated with different diseases. By studying the glycome of individuals or patient cohorts, researchers can unveil disease-specific glycan signatures that can serve as diagnostic or prognostic biomarkers.

Glycomics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global glycomics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Enzymes

Glycosidases

Glycosyltransferases

Neuraminidases

Sialyltransferases

Others

Instruments

Mass Spectrometers

HPLC

MALDI-TOF

Array systems

Others

Kits

Glycan Labeling Kits

Glycan Purification Kits

Glycan Release Kits

Others

Reagents

Glycoproteins

Monosaccharides

Oligosaccharides

Others

Enzymes equipment dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes enzymes (glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and others), instruments (mass spectrometers, HPLC, MALDI-TOF, array systems, and others), kits (glycan labeling kits, glycan purification kits, glycan release kits, and others), reagents (glycoproteins, monosaccharides, oligosaccharides, and others). According to the report, enzymes represented the largest segment.

On the basis of the product, enzymes represent the largest product segment within the market. Enzymes play a crucial role in research and applications by facilitating the analysis and manipulation of glycans. Enzymes, such as glycosidases, glycosyltransferases, and glycosyl hydrolases, are utilized in various workflows, including glycan release, structural analysis, and glycan modification. Moreover, enzymes are essential for the enzymatic cleavage of glycans from glycoproteins or glycolipids, enabling the analysis of liberated glycans. The demand for enzymes in research and applications is driven by the growing need for robust and efficient enzymatic tools. Researchers and scientists rely on enzymes to accurately and selectively manipulate glycans, enabling comprehensive glycomics analysis and the development of glycan-based products. Additionally, advancements in enzyme engineering and optimization have led to the development of highly specific and efficient enzymes, further enhancing their utility in glycomics research.

Breakup by Application:

Drug Discovery and Development

Diagnostics

Others

Drug discovery and development hold the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes drug discovery and development, diagnostics, and others. According to the report, drug discovery and development accounted for the largest market share.

On the basis of application, drug discovery and development represent the largest segment within the overall market. It plays a crucial role in advancing drug discovery and development processes by providing insights into the role of glycans in disease mechanisms, drug efficacy, and safety. Glycans are involved in various biological processes and have been linked to numerous diseases, including cancer, cardiovascular disorders, and infectious diseases. Understanding the glycan profiles and their interactions with proteins and cells is essential for identifying potential therapeutic targets and designing effective drugs. Moreover, the integration with drug discovery and development processes has led to the development of glycan-based therapies, companion diagnostics, and improved drug screening platforms. Also, the focus on targeting glycans in drug discovery and development has driven the demand for research and technologies, making it the largest application segment within the market.

Breakup by End User:

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs)

Academic and research institutes hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). According to the report, academic and research institutes accounted for the largest market share.

Academic and research institutes represent the largest segment of the market. They play a vital role in driving research and advancements in the field. These institutions serve as the primary hubs for scientific research, knowledge generation, and innovation in the field. They are home to leading scientists, researchers, and experts who are actively involved in studying and exploring the complexities of glycans. These institutions also provide the necessary infrastructure, funding, and collaborative opportunities to support the research. They often house state-of-the-art laboratories equipped with advanced analytical instruments and technologies, enabling comprehensive glycan analysis and profiling. Furthermore, academic and research institutes contribute significantly to expanding the knowledge base through publications, scientific conferences, and collaborations. They foster interdisciplinary research collaborations, bringing together experts from various fields such as chemistry, biology, bioinformatics, and medicine.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest glycomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the market. North America is home to several renowned academic institutions, research organizations, and biotechnology companies that have made significant contributions to the research. These institutions have robust research infrastructure, state-of-the-art laboratories, and well-established collaborations, facilitating cutting-edge studies and innovation. Moreover, the region has a well-developed healthcare and biopharmaceutical sector, which drives the demand for research and applications. The presence of major pharmaceutical companies and biotech firms in North America leads to significant investments in the research for drug discovery, personalized medicine, and the development of glycan-based therapeutics. Furthermore, the region has a favorable regulatory environment and strong intellectual property protections that encourage innovation and commercialization of glycomics-based products. The region's well-defined regulatory frameworks provide clarity and guidance for research, ensuring the safety and efficacy of glycan-based diagnostics and therapeutics.

Competitive Landscape:

Companies in the market are involved in various activities related to glycomics research, product development, and commercialization. Several major companies are investing in research and development to advance the understanding of glycans, develop new technologies, and explore applications in various fields. They conduct studies to uncover the roles of glycans in disease mechanisms, identify glycan biomarkers, and understand glycan-protein interactions. Moreover, the companies in the market develop and manufacture products that support the research. This includes enzymes, kits, reagents, and instruments used in glycan analysis, glycan profiling, and glycan modification. These products help researchers in academia, pharmaceutical companies, and research institutes carry out glycomics experiments and investigations. Additionally, some companies focus on translating research into commercial applications. They develop and market glycan-based products for various industries, such as biopharmaceuticals, diagnostics, and nutraceuticals.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Asparia Glycomics

Bruker Corporation

Danaher Corporation

Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)

Merck KGaA

New England Biolabs

RayBiotech Life Inc.

Shimadzu Corporation

Takara Bio Inc.

Thermo Fisher Scientific Inc.

Waters Corporation.

Recent Developments:

In June 2023, Agilent Technologies Inc. launched Agilent BioTek 406 FX washer dispenser, a compact instrument that combines multifunctional reagent dispensing and plate-washing capabilities. The BioTek 406 FX offers expanded liquid handling features designed for integration into automated systems and standalone benchtop use.

In March 2023, Waters Corporation launched Next-Generation Alliance iS HPLC System aimed at reducing Up to 40% of Common Lab Errors. This new product helps laboratories manage operational risk, mitigate disruptions, and increase overall productivity.

In September 2022, Thermo Fisher Scientific Inc. launched the DynaSpin(TM) Single-Use Centrifuge system2. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting. It also improves and streamlines harvesting for cell culture separation in single-use bioprocesses by reducing the number of depth filtration cartridges required to complete the harvest process.

Key Questions Answered in This Report

  • 1. What was the size of the global glycomics market in 2023?
  • 2. What is the expected growth rate of the global glycomics market during 2024-2032?
  • 3. What are the key factors driving the global glycomics market?
  • 4. What has been the impact of COVID-19 on the global glycomics market?
  • 5. What is the breakup of the global glycomics market based on the product?
  • 6. What is the breakup of the global glycomics market based on the application?
  • 7. What is the breakup of the global glycomics market based on end user?
  • 8. What are the key regions in the global glycomics market?
  • 9. Who are the key players/companies in the global glycomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Glycomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Enzymes
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Glycosidases
      • 6.1.2.2 Glycosyltransferases
      • 6.1.2.3 Neuraminidases
      • 6.1.2.4 Sialyltransferases
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Mass Spectrometers
      • 6.2.2.2 HPLC
      • 6.2.2.3 MALDI-TOF
      • 6.2.2.4 Array systems
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Kits
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Glycan Labeling Kits
      • 6.3.2.2 Glycan Purification Kits
      • 6.3.2.3 Glycan Release Kits
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Reagents
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Glycoproteins
      • 6.4.2.2 Monosaccharides
      • 6.4.2.3 Oligosaccharides
      • 6.4.2.4 Others
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Academic and Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Asparia Glycomics
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bruker Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 New England Biolabs
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 RayBiotech Life Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Shimadzu Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Waters Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis